Holocene Advisors
LEGN icon

Holocene Advisors’s Legend Biotech LEGN Stock Holding History

Holocene Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-761,626
Closed -$42.7M – 777
2024
Q1 		$42.7M Sell
761,626
-999,071
-57% -$60.2M 0.16% 163
2023
Q4 		$106M Buy
1,760,697
+491,433
+39% +$31.1M 0.41% 85
2023
Q3 		$85.3M Buy
1,269,264
+362,211
+40% +$25.2M 0.37% 84
2023
Q2 		$62.6M Buy
+907,053
New +$59.3M 0.27% 114

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Holocene Advisors's LEGN Position: Q2 2024 in Review

Holocene Advisors sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 761,626 shares — an estimated $42.7M sold.

Holocene Advisors first reported a position in LEGN in Q2 2023 and held it in 4 quarters. The position peaked at $106M in Q4 2023. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.

  • Holocene Advisors reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
  • Holocene Advisors sold 761,626 Legend Biotech shares in Q2 2024, an estimated $42.7M.
  • Holocene Advisors first reported a position in Legend Biotech in Q2 2023 and held it in 4 quarters.
  • Holocene Advisors's Legend Biotech position peaked at $106M in Q4 2023.
  • 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.

Based on Holocene Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.